Gender differences in radiotherapy: A critical review
- PMID: 40659297
- DOI: 10.1016/j.critrevonc.2025.104843
Gender differences in radiotherapy: A critical review
Abstract
Introduction: Radiotherapy is an effective anticancer agent. Radiosensitivity varies between individuals. While disparities in radiosensitivity between sex have been well documented, most radiotherapy guidelines and clinical trials do not take into account this important sex/gender factor.
Materials and methods: Key references were derived from a PubMed query. Hand searching and clinicaltrials.gov were also used.
Results: This paper contains a narrative report and a critical discussion of the current evidence regarding the interplay between gender and radiotherapy in terms of both treatment tolerance and efficacy.
Conclusions: Personalized treatment approaches and gender-aware clinical trials are essential to optimize patient care and achieve equitable outcomes.
Keywords: Cancer; Gender; Oncology; Precision medicine; Radiotherapy; Sex differences.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Valerio Nardone serves as Associate Editor for Critical Reviews in Oncology/Hematology If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
